Benzinga | Dec 17, 2021 06:55AM EST

BTIG Maintains Buy on Medtronic, Lowers Price Target to $128

BTIG analyst Ryan Zimmerman maintains Medtronic (NYSE:MDT) with a Buy and lowers the price target from $138 to $128.